AR086876A1 - Derivados heterociclicos de sulfonamida - Google Patents

Derivados heterociclicos de sulfonamida

Info

Publication number
AR086876A1
AR086876A1 ARP120102040A ARP120102040A AR086876A1 AR 086876 A1 AR086876 A1 AR 086876A1 AR P120102040 A ARP120102040 A AR P120102040A AR P120102040 A ARP120102040 A AR P120102040A AR 086876 A1 AR086876 A1 AR 086876A1
Authority
AR
Argentina
Prior art keywords
sulfonamide
heterociclic
derivatives
compounds
heterociclic derivatives
Prior art date
Application number
ARP120102040A
Other languages
English (en)
Inventor
Ramulu Poddutoori
Can Wang
Xianglin Zhao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR086876A1 publication Critical patent/AR086876A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Compuestos; composición farmacéutica y proceso de preparación de compuesto de fórmula (1) y (2), y sales farmacéuticamente aceptables de los mismos. Los compuestos se han demostrado como inhibidores de MEK y por lo tanto pueden ser útiles en el tratamiento de enfermedades hiperproliferativas como el cáncer y la inflamación.
ARP120102040A 2011-06-09 2012-06-08 Derivados heterociclicos de sulfonamida AR086876A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1634DE2011 2011-06-09

Publications (1)

Publication Number Publication Date
AR086876A1 true AR086876A1 (es) 2014-01-29

Family

ID=47293670

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102040A AR086876A1 (es) 2011-06-09 2012-06-08 Derivados heterociclicos de sulfonamida

Country Status (5)

Country Link
US (1) US8470878B2 (es)
CN (1) CN103748085A (es)
AR (1) AR086876A1 (es)
TW (1) TW201302721A (es)
UY (1) UY34121A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105384754B (zh) * 2014-09-02 2018-04-20 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
US20190008859A1 (en) 2015-08-21 2019-01-10 Acerta Pharma B.V. Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
WO2023178269A1 (en) * 2022-03-17 2023-09-21 SpringWorks Therapeutics Inc. Treatment of cutaneous neurofibromas with mirdametinib

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045539B2 (en) 2000-12-22 2006-05-16 Astrazeneca Ab Therapeutic benzoxazole compounds
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
US20060106074A1 (en) 2001-11-28 2006-05-18 Peter Bernstein Er-b-selective ligands
NZ544298A (en) 2003-06-26 2009-04-30 Takeda Pharmaceutical Cannabinoid receptor modulators including benzofuran derivatives
GB0420719D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
KR101426093B1 (ko) 2006-02-10 2014-08-01 서미트 코포레이션 피엘씨 뒤시엔느 근이영양증의 치료
CA2675358C (en) 2007-01-19 2016-01-05 Ardea Biosciences, Inc. Inhibitors of mek
UA99731C2 (ru) 2007-07-30 2012-09-25 Ардеа Биосайенсис, Инк Кристаллические полиморфные формы n-(ариламино)сульфонамидов как ингибиторы мэк, композиция (варианты) и применение
ES2617957T3 (es) 2007-08-03 2017-06-20 Summit (Oxford) Limited Combinaciones farmacológicas para el tratamiento de la distrofia muscular de Duchenne
US20110098288A1 (en) 2008-03-11 2011-04-28 Jeremy Major Sulfonamides as zap-70 inhibitors
CN102134218A (zh) 2009-06-15 2011-07-27 凯美隆(北京)药业技术有限公司 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
GEP20135998B (en) * 2009-12-08 2013-12-25 Novartis Ag Heterocyclic sulfonamide derivatives

Also Published As

Publication number Publication date
CN103748085A (zh) 2014-04-23
US8470878B2 (en) 2013-06-25
UY34121A (es) 2013-01-31
TW201302721A (zh) 2013-01-16
US20120316149A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
UY39630A (es) Inhibidores de bromodominios
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
CO2017002998A2 (es) Derivados de tetrahidronaftaleno que inhiben la proteína mcl-1
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
MX2014012695A (es) Derivados de isoindolona.
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
EA201591195A1 (ru) Новые хинолоновые производные
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UA113215C2 (xx) Похідні проліків (e)-n-метил-n-((3-метилбензофуран-2-іл)метил)-3-(7-оксо-5,6,7,8-тетрагідро-1,8-нафтиридин-3-іл)акриламіду
MX2015016425A (es) Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades.
EA201600434A1 (ru) Применение производных бензимидазолпролина
CY1120133T1 (el) Πυριδαζινονες ως αναστολεις ενζυμου daao
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
ECSP12011984A (es) Derivados de sulfonamida heterocíclicos
EA201490573A1 (ru) Соединение бензотиазолона
EA201391820A1 (ru) Гетероциклические сульфонамидные производные
AR086876A1 (es) Derivados heterociclicos de sulfonamida
UY33806A (es) ?compuestos novedosos de imidazoquinolina, composiciones que los contienen y su uso en el tratamiento de enfermedades mediadas por tlr7?

Legal Events

Date Code Title Description
FA Abandonment or withdrawal